?(Fig
?(Fig.7).7). L-nucleotide-protected TLR9 agonists without chemical modification As opposed to CpG-ODN which attain metabolic balance mainly by chemical substance adjustments to its backbone, the brand new category of DNA-based immunomodulators,…